Immunohistochemical localization of the σ1-receptor in oligodendrocytes in the rat central nervous system

Brain Research

Volumn 961, Issue 1, 2003, Pages 92-99

  Palacios, Gabriel ^a   Muro, Asunción ^a   Vela, José Miguel ^b   Molina Holgado, Eduardo ^c   Guitart, Xavier ^a   Ovalle, Sergio ^a   Zamanillo, Daniel ^a  

^a Laboratorios Dr Esteve SA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO CAJAL   (Spain)

Author keywords

Immunohistochemistry; Oligodendrocytes; Rat brain; Sigma1 ( 1) receptor

Indexed keywords

AMINO ACID; NEUROSTEROID; PEPTIDE ANTIBODY; PEPTIDE FRAGMENT; PEROXIDASE; POLYCLONAL ANTIBODY; SIGMA OPIATE RECEPTOR; GALACTOSYLCERAMIDE; MONOCLONAL ANTIBODY; PROTEIN; SIGMA 1 OPIATE RECEPTOR; SIGMA-1 RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MALE; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; SEQUENCE ANALYSIS; STEM CELL; ANIMAL; BRAIN; CYTOLOGY; METABOLISM; TISSUE DISTRIBUTION; WISTAR RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN; GALACTOSYLCERAMIDES; IMMUNOHISTOCHEMISTRY; MALE; OLIGODENDROGLIA; PROTEINS; RATS; RATS, WISTAR; RECEPTORS, SIGMA; TISSUE DISTRIBUTION;

EID: 0037462202     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03892-1     Document Type: Article

References (43)

1. Abney E.R., Williams B.P., Raff M.C. Tracing the development of oligodendrocytes from precursor cells using monoclonal antibodies, fluorescence-activated cell sorting, and cell culture. Dev. Biol. 100:1983;166-171.
2. Almazán G., Afar D.E.H., Bell J.C. Phosphorylation and disruption of intermediate filament proteins in oligodendrocyte precursor cultures treated with calyculin A. J. Neurosci. Res. 36:1993;163-172.
3. 1 receptor in the adult rat central nervous system. Neuroscience. 97:2000;155-170.
4. Bansal R., Warrington A.E., Gard A.L., Ranscht B., Pfeiffer S.E. Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development. J. Neurosci. Res. 24:1989;548-557.
5. Baulieu E.E., Schumacher M. Neurosteroids with special reference to the effect of progesterone on myelination in peripheral nerves. Multiple Sclerosis. 3:1997;105-112.
6. Baumann N., Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Phys. Rev. 81:2001;871-927.
7. Berger T., Walz W., Schnitzer J., Kettenman H. GABA- and glutamate-activated currents in glial cells of the mouse corpus callosum slice. J. Neurosci. Res. 31:1992;21-27.
8. Bongarzone E.R., Howar S.G., Schonmann V., Campagnoni A.T. Identification of the dopamine D3 receptor in oligodendrocyte precursors: potential role in regulating differentiation and myelin formation. J. Neurosci. 18:1998;5344-5353.
9. Bowen W.D. Sigma receptors: recent advances and new clinical potentials. Pharm. Acta Helv. 74:2000;211-218.
10. Chicheportiche R.R., Contreras P.C., Johnson K.M., Lodge D., Tam S.W., Woods J.H., Zukin S.R. Classification and nomenclature of phencyclidine and sigma receptor sites. Trends Pharmacol. Sci. 10:1987;444-446.
11. Demerens C., Stankoff B., Zalc B., Lubetzki C. Eliprodil stimulates CNS myelination. New prospects for multiple sclerosis? Neurology. 52:1999;346-350.
12. 1-binding site. Proc. Natl. Acad. Sci. USA. 93:1996;8072-8077.
13. Hellewel S.B., Bowen W.D. A sigma-like binding site in rat pheochromocytome (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that in guinea pig brain. Brain Res. 527:1990;244-253.
14. Hellewel S.B., Bruce A., Feinstein G., Orringer J., Williams W., Bowen W.D. Rat liver and kidney contain high densities of sigma-1 and sigma-2 receptors: characterization by ligand binding and photoaffinity labeling. Eur. J. Pharmacol., Mol. Pharmacol. Sect. 268:1994;9-18.
15. Howard S., Landry C.F., Fisher R., Bezouglaia O., Handley V., Campagnoni A.T. The postnatal localization and morphogenesis of cells expressing the dopaminergic D2 receptor gene in rat brain: expression in no neuronal cells. J. Comp. Neurol. 391:1998;87-98.
16. Hu Z.Y., Bourreau E., Jung-Testas I., Robel P., Baulieu E.E. Neurosteroids: oligodendrocyte mitochondria convert cholesterol to pregnenolone. Proc. Natl. Acad. Sci. USA. 84:1987;8215-8219.
17. Itzhak Y., Stein I., Zhang S.H., Kassim C.O., Cristante D. Binding of sigma-ligands to C57BL/6 mouse brain membranes: effects of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of sigma-receptor subtypes. J. Pharmacol. Exp. Ther. 257:1991;141-148.
18. Jung-Testas I., Hu Z.Y., Baulieu E.E., Robel P. Neurosteroids: biosynthesis of pregnenolone and progesterone in primary cultures of rat glial cells. Endocrinology. 125:1989;2083-2091.
19. Jung-Testas I., Hu Z.Y., Baulieu E.E., Robel P. Steroid synthesis in rat brain cell cultures. J. Steroid Biochem. 34:1989;511-519.
20. Jung-Testas I., DoThi A., Koenig H., Désarnaud F., Shazand K., Schumacher M., Baulieu E.E. Progesterone as a neurosteroid: synthesis and actions in rat glial cells. J. Steroid. Biochem. Mol. Biol. 69:1999;97-107.
21. Kekuda R., Prasad P.D., Fei Y.-J., Leibach F.H., Ganapathy V., Fei Y.J. Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem. Biophys. Res. Commun. 229:1996;553-558.
22. Knapp P.E., Maderspach K., Hauser K.F. Endogenous opioid system in developing normal and Jimpy oligodendrocytes: mu and kappa opioid receptors mediate differential mitogenic and growth responses. Glia. 22:1998;189-201.
23. Ludwin S.K. The pathobiology of the oligodendrocytes. J. Neuropathol. Exp. Neurol. 56:1997;111-124.
24. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine and nalorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:1976;517-532.
25. Matute C. Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve. Proc. Natl. Acad. Sci. USA. 95:1998;10229-10234.
26. Maurice T., Lockhart B.P. Neuroprotective and anti-amnesic potentials of sigma (σ) receptor ligands. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 21:1997;69-102.
27. 1) receptor: pharmacological evidence and therapeutic opportunities. Jpn. J. Pharmacol. 81:1999;125-155.
28. 3H]SKF-10,047 binding sites (sigma sites) exhibit a unique distribution in rat brain subcellular fractions. Eur. J. Pharmacol. 188:1990;211-218.
29. McCaan D.J., Weissman A.D., Su T.P. Sigma-1 and sigma-2 receptors in the rat brain: comparison of regional, ontogenetic and subcellular patterns. Synapse. 17:1994;182-189.
30. McCarthy K.D., de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell. Biol. 85:1980;890-902.
31. 1 receptor. Biochem. Pharmacol. 62:2001;349-355.
32. Moebius F.F., Striessnig J., Glossmann H. The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. Trends Pharmacol. Sci. 18:1997;67-70.
33. 7 isomerase. Br. J. Pharmacol. 121:1997;1-6.
34. 1 receptor modulates phospholipase C and protein kinase C activities in the brainstem. Proc. Natl. Acad. Sci. USA. 96:1999;8196-8199.
35. 1 receptor. J. Neurochem. 70:1998;2279-2285.
36. Quirion R., Bowen W.D., Itzhak Y., Junien J.L., Musacchio J.M., Rothman R.B., Su T.-P., Tam S.W., Taylor D.P. A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 13:1992;85-86.
37. Raff M.C., Lillien L.E., Richardson W.D., Burne J.F., Noble M.D. Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature. 333:1988;562-565.
38. Ranscht B., Clapshaw P.A., Price J., Noble M., Seifert W. Development of oligodendrocytes and schwann cells studied with a monoclonal antibody against galactocerebroside. Proc. Natl. Acad. Sci. USA. 79:1982;2709-2713.
39. Reynolds R., Hardy R. Oligodendroglial progenitors labeled with the O4 antibody persist in the adult rat cerebral cortex in vivo. J. Neurosci. Res. 47:1997;455-470.
40. Vilner B.J., John C.S., Bowen W.D. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res. 55:1995;408-413.
41. Walker J.M., Bowen W.D., Walker F.O., Matsumoto R.R., de Costa B.R., Rice K.C. Sigma receptors: biology and function. Pharmacol. Rev. 42:1990;355-402.
42. Wolfe S.A. Jr., DeSouza E.B. Sigma receptors in the brain-endocrine-immune axis. Kamenka J.M., Domino E.F. Multiple Sigma and PCP Receptor Ligands: Mechanisms For Neuromodulation and Neuroprotection. 1992;927-958 NPP Books, Ann Arbor.
43. Zamanillo D., Romero G., Dordal A., Pérez P., Vincent L., Méndez R., Andreu F., Hernández E., Pérez R., Monroy X., Ovalle S., Guitart X. Increase of forskolin-stimulated adenylyl cyclase and AP-1 activities by sigma 1 receptor expression. Forum of European Neuroscience FENS, Paris, France, July 2002.